Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

Clinical trial NCT01469169 · COMPLETED

Trial details

NCT number: NCT01469169
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2012-06-19
Primary completion: 2014-12-26
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.